Literature DB >> 15523051

Receptor-independent activation of GABAergic neurotransmission and receptor-dependent nontranscriptional activation of phosphatidylinositol 3-kinase/protein kinase Akt pathway in short-term cardiovascular actions of dexamethasone at the nucleus tractus solitarii of the rat.

Ling-Lin Wang1, Chen-Chun Ou, Julie Y H Chan.   

Abstract

Whereas glucocorticoids are important blood pressure regulators via an action on peripheral circulation, their roles in central cardiovascular regulation are less known. This study evaluated the short-term cardiovascular effect of glucocorticoid in the nucleus tractus solitarii (NTS) and delineated the underlying molecular mechanisms. In Sprague-Dawley rats maintained under propofol anesthesia, microinjection bilaterally into the NTS of a synthetic glucocorticoid, dexamethasone (Dex; 12.5, 25, 50, or 100 pmol), elicited hypertensive and tachycardiac responses. The initial cardiovascular responses, which lasted 15 to 30 min, were blunted by coadministration of a selective GABA(A) or GABA(B) receptor antagonist, bicuculline (15 pmol) or 2-hydroxy saclofen (150 pmol). The delayed responses, which endured at least 90 min and entailed maintained hypertension and tachycardia, were reversed by selective glucocorticoid type II receptor (GR) antagonist mifepristone (100 or 200 pmol), phosphatidylinositol 3-kinase (PI3K) inhibitor LY294002 [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one] (20 nmol), or nitric-oxide synthase inhibitor N(G)-monomethyl-l-arginine acetate (5 nmol), but not by the RNA synthesis inhibitor actinomycin D (20 nmol). Moreover, Dex induced an association of GR with the regulatory subunit of PI3K, p85alpha, in a ligand-dependent manner and promoted serine/threonine kinase Akt phosphorylation that was blocked by coadministration of mifepristone or LY294002. These cardiovascular and molecular responses occurred when translocation of activated GR into the nucleus was minimal. Our results indicate that Dex acts on the NTS to elicit hypertension and tachycardia via both a GR-independent interaction with GABA(A) and GABA(B) receptors and a GR-dependent but nontranscriptional mechanism that involves activation of PI3K/Akt pathway.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15523051     DOI: 10.1124/mol.104.005595

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  7 in total

1.  Macrophage glucocorticoid receptors regulate Toll-like receptor 4-mediated inflammatory responses by selective inhibition of p38 MAP kinase.

Authors:  Sandip Bhattacharyya; Diane E Brown; Judson A Brewer; Sherri K Vogt; Louis J Muglia
Journal:  Blood       Date:  2007-01-25       Impact factor: 22.113

2.  Chronic activation of dorsal hindbrain corticosteroid receptors augments the arterial pressure response to acute stress.

Authors:  Deborah A Scheuer; Andrea G Bechtold; Kathy A Vernon
Journal:  Hypertension       Date:  2006-11-06       Impact factor: 10.190

3.  Chronic blockade of hindbrain glucocorticoid receptors reduces blood pressure responses to novel stress and attenuates adaptation to repeated stress.

Authors:  Andrea G Bechtold; Gina Patel; Guenther Hochhaus; Deborah A Scheuer
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-03-11       Impact factor: 3.619

4.  Caveolin mediates rapid glucocorticoid effects and couples glucocorticoid action to the antiproliferative program.

Authors:  L Matthews; A Berry; V Ohanian; J Ohanian; H Garside; D Ray
Journal:  Mol Endocrinol       Date:  2008-02-28

5.  Hypertension and other morbidities with Cushing's syndrome associated with corticosteroids: a review.

Authors:  Melpomeni Peppa; Maria Krania; Sotirios A Raptis
Journal:  Integr Blood Press Control       Date:  2011-03-03

6.  Dexamethasone rapidly increases GABA release in the dorsal motor nucleus of the vagus via retrograde messenger-mediated enhancement of TRPV1 activity.

Authors:  Andrei V Derbenev; Bret N Smith
Journal:  PLoS One       Date:  2013-07-30       Impact factor: 3.240

7.  Roles of PI3K/AKT/PTEN Pathway as a Target for Pharmaceutical Therapy.

Authors:  Satoru Matsuda; Atsuko Nakanishi; Yoko Wada; Yasuko Kitagishi
Journal:  Open Med Chem J       Date:  2013-10-31
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.